• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情下的政治决策:以风险管理视角看德国的情况。

Political Decision Making in the COVID-19 Pandemic: The Case of Germany from the Perspective of Risk Management.

机构信息

Faculty of Social and Behavioural Sciences, Friedrich Schiller University Jena, 07743 Jena, Germany.

Faculty of Management, Seeburg Castle University, 5201 Seekirchen, Austria.

出版信息

Int J Environ Res Public Health. 2021 Dec 30;19(1):397. doi: 10.3390/ijerph19010397.

DOI:10.3390/ijerph19010397
PMID:35010656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8744640/
Abstract

The COVID-19 pandemic is permanently changing modern social and economic coexistence. Most governments have declared infection control to be their top priority while citizens face great restrictions on their civil rights. A pandemic is an exemplary scenario in which political actors must decide about future, and thus uncertain, events. This paper tries to present a tool well established in the field of entrepreneurial and management decision making which could also be a first benchmark for political decisions. Our approach builds on the standard epidemiological SEIR model in combination with simulation techniques used in risk management. By our case study we want to demonstrate the opportunities that risk management techniques, especially risk analyses using Monte Carlo simulation, can provide to policy makers in general, and in a public health crisis in particular. Hence, our case study can be used as a framework for political decision making under incomplete information and uncertainty. Overall, we want to point out that a health policy that aims to provide comprehensive protection against infection should also be based on economic criteria. This is without prejudice to the integration of ethical considerations in the final political decision.

摘要

新冠疫情正在永久性地改变现代社会和经济的共存方式。大多数政府都将感染控制作为首要任务,而公民的公民权利则受到极大限制。大流行是政治行为者必须对未来的、不确定的事件做出决策的典型情况。本文试图提出一种在创业和管理决策领域已经确立的工具,该工具也可以作为政治决策的第一个基准。我们的方法基于标准的流行病学 SEIR 模型,结合风险管理中使用的模拟技术。通过我们的案例研究,我们希望展示风险管理技术,特别是使用蒙特卡罗模拟进行风险分析,能够为政策制定者提供的机会,特别是在公共卫生危机中。因此,我们的案例研究可以作为在不完全信息和不确定性下进行政治决策的框架。总的来说,我们想指出,旨在提供全面感染防护的卫生政策也应该基于经济标准。这并不影响最终政治决策中纳入伦理考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/eb7acbc03ed4/ijerph-19-00397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/ab39f568dd02/ijerph-19-00397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/980b3e3189d1/ijerph-19-00397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/13d863e7b90a/ijerph-19-00397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/ee7ca3a6181e/ijerph-19-00397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/340da07c7fc1/ijerph-19-00397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/eb7acbc03ed4/ijerph-19-00397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/ab39f568dd02/ijerph-19-00397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/980b3e3189d1/ijerph-19-00397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/13d863e7b90a/ijerph-19-00397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/ee7ca3a6181e/ijerph-19-00397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/340da07c7fc1/ijerph-19-00397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a9b/8744640/eb7acbc03ed4/ijerph-19-00397-g006.jpg

相似文献

1
Political Decision Making in the COVID-19 Pandemic: The Case of Germany from the Perspective of Risk Management.新冠疫情下的政治决策:以风险管理视角看德国的情况。
Int J Environ Res Public Health. 2021 Dec 30;19(1):397. doi: 10.3390/ijerph19010397.
2
[Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].[新冠疫情期间德国公共卫生政策制定中的专家委员会:文献分析]
Z Evid Fortbild Qual Gesundhwes. 2021 Oct;165:1-12. doi: 10.1016/j.zefq.2021.06.002. Epub 2021 Aug 30.
3
EU's Ordering of COVID-19 Vaccine Doses: Political Decision-Making under Uncertainty.欧盟订购 COVID-19 疫苗剂量:不确定性下的政治决策。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2169. doi: 10.3390/ijerph18042169.
4
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics.公众对控制 SARS-CoV-2 大流行的非药物干预措施的偏好:公共卫生、个人权利和经济学之间的权衡。
Eur J Health Econ. 2022 Dec;23(9):1483-1496. doi: 10.1007/s10198-022-01438-w. Epub 2022 Feb 9.
5
[COVID-19: Special Challenges for Theoretical and Practical Public Health].[新冠疫情:理论与实践公共卫生面临的特殊挑战]
Gesundheitswesen. 2020 Nov;82(11):829-835. doi: 10.1055/a-1276-0847. Epub 2020 Nov 13.
6
PaCAR: COVID-19 Pandemic Control Decision Making via Large-Scale Agent-Based Modeling and Deep Reinforcement Learning.PaCAR:通过大规模基于代理的建模和深度强化学习进行 COVID-19 大流行控制决策。
Med Decis Making. 2022 Nov;42(8):1064-1077. doi: 10.1177/0272989X221107902. Epub 2022 Jul 1.
7
Should policy makers trust composite indices? A commentary on the pitfalls of inappropriate indices for policy formation.政策制定者是否应该信任综合指数?对不适当的政策制定指数的陷阱的评论。
Health Res Policy Syst. 2021 Mar 22;19(1):40. doi: 10.1186/s12961-021-00702-4.
8
Making Drug Approval Decisions in the Face of Uncertainty: Cumulative Evidence versus Value of Information.面对不确定性制定药物审批决策:累积证据与信息价值。
Med Decis Making. 2024 Jul;44(5):512-528. doi: 10.1177/0272989X241255047. Epub 2024 Jun 3.
9
WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.WICID 框架 1.0 版:指导针对 COVID-19 的非药物干预措施进行循证决策的标准和考虑因素。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003699.
10
Sound Decision Making in Uncertain Times: Can Systems Modelling Be Useful for Informing Policy and Planning for Suicide Prevention?不确定时期的明智决策:系统建模能否有助于为自杀预防政策和规划提供信息?
Int J Environ Res Public Health. 2022 Jan 27;19(3):1468. doi: 10.3390/ijerph19031468.

引用本文的文献

1
Healthcare workers' experiences with COVID-19-related prevention and control measures in Tanzania.坦桑尼亚医护人员在新冠疫情防控措施方面的经历
PLOS Glob Public Health. 2023 Dec 5;3(12):e0002678. doi: 10.1371/journal.pgph.0002678. eCollection 2023.
2
Predictive potential of SARS-CoV-2 RNA concentration in wastewater to assess the dynamics of COVID-19 clinical outcomes and infections.污水中 SARS-CoV-2 RNA 浓度对评估 COVID-19 临床结局和感染动态的预测潜力。
Sci Total Environ. 2023 Aug 15;886:163935. doi: 10.1016/j.scitotenv.2023.163935. Epub 2023 May 8.
3
Public Health Decision Making in the Case of the Use of a Nuclear Weapon.

本文引用的文献

1
EU's Ordering of COVID-19 Vaccine Doses: Political Decision-Making under Uncertainty.欧盟订购 COVID-19 疫苗剂量:不确定性下的政治决策。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2169. doi: 10.3390/ijerph18042169.
2
COVID-19 and the Political Economy of Mass Hysteria.新冠疫情与群体歇斯底里的政治经济学
Int J Environ Res Public Health. 2021 Feb 3;18(4):1376. doi: 10.3390/ijerph18041376.
3
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany.
公共卫生决策在使用核武器情况下的思考。
Int J Environ Res Public Health. 2022 Oct 6;19(19):12766. doi: 10.3390/ijerph191912766.
4
A Longitudinal Study on Loneliness during the COVID-19 Pandemic in Japan.一项关于日本 COVID-19 大流行期间孤独感的纵向研究。
Int J Environ Res Public Health. 2022 Sep 7;19(18):11248. doi: 10.3390/ijerph191811248.
5
Cost-effectiveness of future lockdown policies against the COVID-19 pandemic.未来封锁政策应对 COVID-19 大流行的成本效益。
Health Serv Manage Res. 2023 Feb;36(1):51-62. doi: 10.1177/09514848221080687. Epub 2022 Apr 5.
在德国,为应对 COVID-19 疫情,多少张重症监护病床是合理的?一项成本效益分析。
Appl Health Econ Health Policy. 2021 Mar;19(2):181-190. doi: 10.1007/s40258-020-00632-2. Epub 2021 Jan 12.
4
Inferring the effectiveness of government interventions against COVID-19.推断政府干预 COVID-19 的效果。
Science. 2021 Feb 19;371(6531). doi: 10.1126/science.abd9338. Epub 2020 Dec 15.
5
Ranking the effectiveness of worldwide COVID-19 government interventions.对全球 COVID-19 政府干预措施的效果进行排名。
Nat Hum Behav. 2020 Dec;4(12):1303-1312. doi: 10.1038/s41562-020-01009-0. Epub 2020 Nov 16.
6
The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany.德国在新冠疫情期间成功实施封锁措施的临床和经济价值。
Q Rev Econ Finance. 2022 May;84:502-509. doi: 10.1016/j.qref.2020.10.007. Epub 2020 Oct 14.
7
How confidence in health care systems affects mobility and compliance during the COVID-19 pandemic.医疗体系信任度如何影响 COVID-19 大流行期间的流动性和遵从性。
PLoS One. 2020 Oct 15;15(10):e0240644. doi: 10.1371/journal.pone.0240644. eCollection 2020.
8
SEIR modeling of the COVID-19 and its dynamics.COVID-19的SEIR模型及其动态变化
Nonlinear Dyn. 2020;101(3):1667-1680. doi: 10.1007/s11071-020-05743-y. Epub 2020 Jun 18.
9
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders.每获得一个质量调整生命年的增量成本?评估超罕见疾病医疗干预措施的替代方法的必要性。
J Comp Eff Res. 2014 Jul;3(4):399-422. doi: 10.2217/cer.14.34.
10
Calculating QALYs, comparing QALY and DALY calculations.计算质量调整生命年,比较质量调整生命年和伤残调整生命年的计算。
Health Policy Plan. 2006 Sep;21(5):402-8. doi: 10.1093/heapol/czl018. Epub 2006 Jul 28.